Susan K Strotheide, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1320 W State St, Ste 3a, Belding, MI 48809 Phone: 616-794-1810 Fax: 616-794-1947 |
Mrs. Abby Lynn Hogue, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 8690 Krupp Rd, Belding, MI 48809 Phone: 616-914-7183 |
Emily Wallace, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1320 W State St Ste 3a, Belding, MI 48809 Phone: 616-794-1810 |
Olivia Rose Borchers, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1320 W State St # 3a, Belding, MI 48809 Phone: 248-763-3701 |
Allison Plakmeyer, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 420 Covered Vlg, Belding, MI 48809 Phone: 616-430-2924 |
News Archive
Democrats and Republicans are crystal clear in polls that they want government to be allowed to negotiate down high drug prices. Americans pay nearly three times as much for drugs as patients in dozens of other countries.
A heathy diet is linked to better reading skills in the first three school years, shows a recent study from Finland. Published in the European Journal of Nutrition, the study constitutes part of the Physical Activity and Nutrition in Children Study conducted at the University of Eastern Finland and the First Steps Study conducted at the University of Jyväskylä.
Cryotherapy, an interventional radiology treatment to freeze cancer tumors, may become the treatment of the future for cancer that has metastasized in soft tissues (such as ovarian cancer) and in bone tumors.
The Virginia Commonwealth University Mood Disorders Institute is recruiting participants for a national study of a new treatment method for premenstrual dysphoric disorder, a severe and debilitating form of premenstrual syndrome, or PMS.
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced the initiation of a dose escalation study with its oncology drug candidate tamibarotene combined with TRISENOX® (arsenic trioxide) injection (marketed by Cephalon, Inc.) in patients with relapsed acute promyelocytic leukemia (APL).
› Verified 3 days ago